ARCA biopharma, Inc. is a biopharmaceutical company developing genetically-targeted therapies for heart failure and other cardiovascular diseases. ARCA began operations in 2005 and is headquartered in Broomfield, Colorado.
Annual Shareholder Meeting Information:
When: May 21st, 2010 at 9:00 am MDT
Where: Renaissance Suites, 500 Flatiron Blvd., Broomfield, CO 80021
For directions to the Renaissance Suites, please click here.
To view and print ARCA biopharma, Inc.'s Annual Report on Form 10-K, please click here.
To view and print ARCA biopharma, Inc.'s Proxy Statement, please click here.
To view and print ARCA biopharma, Inc.'s Stockholder Meeting Notice, please click here.
